Centro Médico Teknon
Dr. Pablo de la Cuadra (Pablo Cuadra de la Virgili) is an orthopedic surgeon and traumatologist in Madrid. He specializes in sports injuries and shoulder surgery at Hospital Ruber Internacional, where he has worked since 1999. He has over 25 years of experience. He leads a multidisciplinary unit and heads a specialized traumatology team. He is a recognized expert in complex shoulder disorders. He uses advanced arthroscopic and reconstructive techniques for instability and rotator cuff injuries.
Accreditations: MD (1993) and PhD in Medicine (2001), Autonomous University of Madrid. Specialist in Orthopedic Surgery and Traumatology after residency at Hospital Puerta de Hierro (1995–1999). Current roles: Orthopedic Specialist at Centro Médico Habana (1999–present) and Specialist Physician at Hospital Puerta de Hierro (2000–present). He is also an Associate Professor of Health Sciences at the Autonomous University of Madrid.
Barcelona and Madrid are the primary destinations for arthritis stem cell therapy in Spain. Barcelona leads in regenerative innovation with JCI-accredited facilities like Centro Medico Teknon. Madrid offers high-level orthopedic expertise at centers such as Quironsalud Madrid, specializing in complex joint reconstructions and cellular treatments.
Bookimed Expert Insight: Barcelona stands out because clinics like Centro Medico Teknon have treated high-profile professional athletes. This high-volume clinical experience with regenerative therapy results in more refined protocols for arthritis. Patients often find better value here than in Madrid because the concentrated expertise attracts more specialized medical coordinators.
Patient Consensus: Most patients recommend prioritizing Barcelona or Madrid for established clinics with English-speaking staff. They suggest budgeting for potential follow-up care and tracking joint mobility outcomes for 12 months.
Stem cell therapy for arthritis is legal in Spain under a strict regulatory framework managed by the Spanish Agency of Medicines and Medical Devices (AEMPS). It is classified as an Advanced Therapy Medicinal Product (ATMP), requiring pharmaceutical-grade validation for safety and efficacy.
Bookimed Expert Insight: Spain attracts high-profile athletes for regenerative care because top-tier centers like Centro Médico Teknon integrate stem cell therapy into trauma recovery. While treatments cost $6,000 to $11,000, verify if your specialist, such as Dr. Luís Orozco Delclós, is part of the Cell Therapy Network to ensure legal compliance.
Patient Consensus: Patients emphasize verifying clinic registration with AEMPS and requesting pre-treatment MRI evidence. Many report significant pain relief for 1–2 years, though they advise caution regarding claims of full cartilage regrowth.
Stem cell therapy does not cure arthritis or regrow missing cartilage. It is an experimental treatment for managing local inflammation and increasing mobility. Most patients achieve significant pain relief for 2 to 5 years, though advanced bone-on-bone cases still require joint replacement surgery.
Bookimed Expert Insight: Spain attracts many professional athletes, including FC Barcelona players, to clinics like Centro Médico Teknon for regenerative treatments. While the $6,000 to $11,000 cost is higher than some regions, these facilities are JCI-accredited and led by researchers like Dr. Luís Orozco Delclós. High patient volumes of 10,000 people annually suggest a high level of procedural refinement, even if the therapy remains a management tool rather than a permanent cure.
Patient Consensus: Most patients describe the procedure as managing symptoms better rather than providing a miracle fix. They emphasize that while pain decreases significantly, it is vital to view this as a way to delay surgery rather than skip it entirely.
Public healthcare in Spain (SNS) generally excludes stem cell therapy for
Stem cell therapy for arthritis in Spain shows subjective improvement rates between 30% and 70%. Effects typically peak at 3 months and last 6 months to 2 years. Patients under 50 with early-stage osteoarthritis often experience the most durable results from these regenerative treatments.
Bookimed Expert Insight: Spain attracts 10,000+ patients annually partly due to specialists like Dr. Javier Albiñana and Dr. Luís Orozco Delclós. While costs are 55% lower than US averages, longevity varies by case severity. We see higher satisfaction rates when patients confirm cell viability tests are performed before the injection.
Patient Consensus: Many patients report significant pain reduction for 9 months before symptoms gradually return. Those with severe arthritis often find minimal lasting change and suggest budgeting for regular maintenance sessions.
Spanish doctors primarily use Mesenchymal Stem Cells (MSCs) to treat arthritis. They utilize autologous bone marrow-derived MSCs and adipose-derived stem cells (ADSCs) from the patient's own tissue. Allogeneic MSCs from donors are also available at advanced regenerative institutes for rheumatoid conditions.
Bookimed Expert Insight: Spain stands out globally because its regulatory framework allows for culture-expanded stem cell treatments. While most countries only permit simple tissue spin-downs, Spanish doctors like Dr. Luís Orozco Delclós at Centro Médico Teknon can multiply your own cells in a lab. This process creates a much higher dose than standard injections, which is why celebrities and professional athletes frequently choose Barcelona for joint recovery.
Patient Consensus: Patients often recommend checking endoscopy reports to verify cell types and counts. Many find that combining autologous stem cells with PRP injections provides more effective long-term pain relief for osteoarthritis.
Spain's top stem cell clinics are concentrated in Barcelona and Madrid, with Pamplona serving as a secondary research hub. Barcelona leads in biomedical infrastructure, while Madrid offers private medical centers specializing in musculoskeletal regeneration. All clinics operate under strict Spanish Agency of Medicines (AEMPS) regulations.
Bookimed Expert Insight: While Madrid and Barcelona dominate, Barcelona clinics like Teknon serve over 10,000 patients annually. They often treat elite professional athletes for trauma. This high volume across 50+ specialized departments ensures surgeons maintain elite proficiency in complex regenerative procedures.
Patient Consensus: Patients recommend choosing university-affiliated hospitals in Barcelona for greater legitimacy. They advise documenting pre- and post-therapy MRIs to track actual long-term tissue improvement accurately.
Patients typically need to stay in Spain for 7 to 10 days to complete stem cell therapy for arthritis. This timeframe allows for initial consultations, cell harvesting, laboratory processing under strict EU regulations, the actual intra-articular injection, and vital post-procedure monitoring for infection or inflammation.
Bookimed Expert Insight: Spain’s stricter adherence to EU cell-processing regulations often requires a longer 10-day stay compared to faster 3-day protocols elsewhere. Data from top-tier facilities like Centro Médico Teknon suggests this extra time facilitates high-precision cell cultivation, which is why elite athletes frequently choose Barcelona for regenerative treatments.
Patient Consensus: Patients recommend booking flexible lodging for the final days to manage potential arthritis flare-ups. Many suggest prioritizing clinics with English-speaking staff to clarify complex multi-day lab schedules.